查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853860

全球单光子发射电脑断层扫描市场（检测器、最终用户、产品和应用划分）—2025-2032年全球预测

Single Photon Emission Computed Tomography Market by Detector, End User, Product, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，单光子发射电脑断层扫描市场规模将达到 30.2 亿美元，复合年增长率为 4.08%。

主要市场统计数据
基准年 2024 21.9亿美元
预计年份：2025年 22.8亿美元
预测年份：2032年 30.2亿美元
复合年增长率 (%) 4.08%

本文简要介绍了SPECT的现状，重点阐述了其临床可靠性、技术变革以及诊断阅片者的采购注意事项。

单光子发射电脑断层扫描（SPECT）仍然是核子医学的基石技术，它在循环系统、神经科和肿瘤学领域具有广泛的临床效用和功能成像能力。过去十年来的技术发展使该技术从类比检测器架构过渡到数位和半导体架构，从而提高了计数灵敏度、空间分辨率和工作流程整合度。这些进步与临床实践的变化同步发生，并影响放射性药物的物流、成像方案以及诊断中心和医院系统的设备更新换代週期。

临床医生仍依赖SPECT进行心肌灌注显像、脑灌注评估以及标靶肿瘤学研究，在这些研究中，基于代谢和受体的显像可以与解剖学方法形成互补。随着医疗系统优先考虑以金额为准和诊断效率，SPECT凭藉其多样化的检测器技术和模组化产品配置，能够适应各种临床应用场景，从大型心臟病实验室到专业研究机构均可适用。因此，采购负责人和影像处理管理人员在规划设备升级或新购置时，必须考虑临床需求、机构吞吐量和生命週期成本。

从既有实践向创新主导的过渡，需要将技术性能与临床通讯协定进行精细匹配。因此，相关人员应检测器。

SPECT成像中检测器的突破、人工智慧重建技术的应用以及不断发展的临床工作流程，正在重新定义诊断预期和筹资策略。

由于检测器的创新、软体智慧化以及临床工作流程的改变，SPECT领域正在经历显着的变化。新型检测器技术正推动系统从笨重的碘化钠晶体向紧凑的碲化镉锌和先进的固体感测器过渡，这些感测器具有固有的能量分辨率和更短的死时间。同时，影像重建演算法和人工智慧驱动的后处理正在增强病灶的检测和定量能力，从而改变人们对诊断准确性和报告时间的预期。

临床医生越来越多地将功能性SPECT数据与CT衍生的衰减校正和解剖学关联相结合，以提高诊断的准确性。同时，医疗服务模式的转变，例如门诊影像的整合和心臟影像专科中心的激增，正促使采购重点转向兼顾吞吐量和成本效益的系统。不断变化的供应链动态和监管环境也推动製造商和用户寻求多样化的筹资策略和模组化升级方案。

挑战主要体现在两个方面：一是提升临床效用和以病人为中心的工作流程的机会；二是技术选择与长期耐受性、放射性药物供应以及不断变化的报销模式之间复杂协调的难题。因此，策略规划必须兼顾技术的快速发展与永续的营运模式。

评估累积关税如何重塑SPECT设备製造商和医疗保健提供者的供应链、采购时间表和筹资策略

美国近期加征的关税加剧了全球医疗设备供应链的敏感性，对SPECT系统製造商、经销商和终端用户都产生了累积影响。半导体检测器、精密机械零件和专用电子元件等组件的成本易受关税影响而上涨，这可能导致医院和诊断中心的土地购置成本增加，并使资本采购週期更加复杂。为此，製造商正在重新评估其采购布局和供应合同，以在确保产品供应的同时降低风险。

因此，许多供应商正在加快关键零件的在地化进程，与替代供应商建立合作关係，并调整物流策略以降低关税风险。此类调整通常涉及将组装业务转移到近岸地区、重新谈判供应商条款以及重新设计产品架构以使用更容易购买的子系统。采购团队则透过延长资本项目的前置作业时间，并将供应商的稳定性和长期服务协议置于短期价格优势之上来应对这些变化。

从营运角度来看，影像中心可能会面临更长的采购週期和更高的购置成本，这将影响升级速度和高通量设备的优先部署。因此，临床医生和管理人员应将关税相关的供应链不确定性纳入资本规划，以基于情境的采购蓝图取代组件供应稳定的假设。这些路线图应强调灵活性、全生命週期服务支援以及针对投入成本波动的合约保障。

主导深度细分，将检测器技术、终端用户优先顺序、产品架构和临床应用与采购和临床策略连结起来，从而获得洞察。

对检测器技术的细分揭示了临床应用优先事项的明显差异。碲化镉锌检测器和先进的固体探测器，包括锗半导体和硅光电倍增器，因其卓越的能量分辨率和计数灵敏度而备受青睐，尤其适用于需要检测弱电离离子的应用。相较之下，碘化钠闪烁探测器因其成本效益和成熟的工作流程而广泛应用，在许多进行大量成像的诊断中心仍然占据一席之地。这些检测器的差异不仅影响影像质量，也影响服务需求、培训需求和资金分配决策。

终端使用者细分凸显了诊断中心、医院和研究机构在采购驱动因素上的差异。诊断中心优先考虑吞吐量和单次扫描成本效率，通常倾向于工作流程简化且可快速重新配置的系统。公立和私立医院则需要在临床多功能性和预算限制之间寻求平衡。私人医院可能优先考虑高端检测器和整合服务包以提升其竞争优势，而公立医院则往往更重视稳定的正常执行时间、标准化的通讯协定和长期维护协议。研发机构则更青睐可配置性和先进的检测技术，以支援通讯协定开发和探索性应用。

产品配置也会影响购买决策。单探头系统适用于空间受限或低容量环境；双探头仪器为普通心臟病学和肿瘤学应用提供均衡的吞吐量和灵活性；而当高灵敏度和快速采集至关重要时，则会选择三探头系统。应用领域细分为心臟病学、神经病学和肿瘤学，持续影响系统需求。心臟病学需要快速门控通讯协定，神经病学强调灌注定量，而肿瘤学则需要靶向示踪剂相容性和定量工作流程。这些细分层次决定了相关人员在选择 SPECT 解决方案时必须协调的技术规格、服务模式和采集优先顺序。

亚太地区、中东和非洲以及美洲的区域动态和采用模式对SPECT系统的采购、部署和维护能力产生影响。

区域动态对SPECT系统的应用模式与策略重点有显着影响。美洲地区对先进心臟成像的需求高度集中，由此形成了一个强大的供应商生态系统，支持检测器创新技术的快速临床转化。在该地区，私人影像中心和医院网路通常优先考虑吞吐量和整合服务合同，这为模组化系统升级和高端检测器的部署创造了有利条件。法规环境和报销机制也进一步影响新技术在临床实务中的评估和应用。

儘管高所得的欧洲市场正稳步采用先进的数位检测器和混合工作流程，但中东和非洲市场的特点是投资选择性地集中在三级医院和专科中心。鑑于跨境零件供应的物流复杂性，这些地区通常优先考虑可靠性和长期可维护性。与此同时，亚太地区在不断增长的中阶医疗保健需求、对心臟病和影像处理中心的投资以及降低先进检测器系统采购门槛的本地製造倡议的推动下，正在快速推进其影像基础设施的现代化。

在每个地区，放射性药物的供应、训练系统和医疗政策重点等当地因素都会影响医疗机构如何决定升级和部署SPECT系统的优先顺序。因此，区域策略必须整合临床需求、供应链韧性和监管合规性，以优化部署并确保永续营运。

竞争格局、卓越服务以及硬体创新者和软体开发商之间的伙伴关係如何塑造 SPECT 供应商格局

SPECT 生态系统的竞争主要由跨国影像设备製造商和专注于检测器创新或特定临床解决方案的专业公司组成。大型成熟的医疗影像公司利用其全球服务网络和一体化产品系列与医疗机构签订合同，并持续提供可预测的全生命週期支持；而规模较小的专业公司则凭藉尖端的检测器技术、紧凑的外形尺寸或软体主导的图像增强功能脱颖而出。设备製造商和软体开发商之间的伙伴关係日益重要，这使得重建演算法和人工智慧辅助诊断工具能够不断迭代更新。

能够提供全面培训专案、预测性维护和快速零件供应的供应商更有可能与医院和诊断连锁机构签订长期合约。此外，与放射性药物供应商和临床研究机构倡议，能够促进多中心研究和方案标准化，从而增强供应商的价值提案。因此，资本设备采购委员会和影像科主管在评估供应商时，不仅会考虑设备性能，还会考虑整体拥有成本、升级途径和已证实的临床结果。

创新研发的重点在于检测器小型化、能量阀改进以及提升定量报告的软体平台。软硬体的进步为新参与企业挑战现有产品提供了途径，而现有企业则透过收购、合作和内部研发项目来保持竞争力。最终，竞争成功取决于能否将技术差异化与可靠的服务模式以及临床应用效果结合。

医疗保健主管和供应商在采用 SPECT 技术时，应采取切实可行的策略措施，协调采购、临床效用和供应链弹性。

计划投资SPECT技术的产业领导者应优先考虑模组化、供应链弹性和临床应用相容性，以确保其资本决策面向未来。在选择新系统时，决策者应要求提供灵活的升级路径，以便在无需更换整个系统的情况下改进检测器和软体。筹资策略还应包括供应商多元化和合约保护，以降低关税和地缘政治造成的供应中断风险。

在临床方面，各机构应将采购标准与高影响力应用相符。优先考虑那些能够显着提升心臟病学、神经病学或肿瘤学工作流程诊断信心，并能与PACS和报告基础设施无缝整合的系统。投资于员工培训和规范通讯协定，以提升先进检测器和重建软体的临床价值，并确保影像处理效能的提升能转化为病患管理的改善。在营运方面，应优先考虑全生命週期支援协议和备件物流，以最大限度地延长运作并确保可预测的营运成本。

最后，与产业伙伴合作进行先驱性研究和分阶段推广，可以降低推广风险，同时获得临床和营运效益的本地证据。透过将灵活的技术规范与强大的服务框架和循证伙伴关係相结合，企业领导者可以确保其影像资产能够持续提供临床价值和营运韧性。

结合临床医师访谈、技术检验和二手文献整合的严谨多方法研究途径，确保了对SPECT技术的可靠和透明的见解。

本研究采用多方法结合的方式，融合了第一手资料、二手资料和技术检验。第一手资料包括对临床终端使用者、影像物理学家、采购负责人和设备工程师进行结构化访谈，以了解他们对效能要求、操作挑战和服务期望的现场观点。此外，还咨询了监管专家，以解读核准管道和合规性问题对设备部署时间表的影响，从而补充了这些定性见解。

二次研究涵盖了同行评审文献、临床指南、製造商技术规范以及公开的监管文件，旨在建立关于检测器性能特征、成像通讯协定和特定应用要求的可靠依证。尽可能透过参与机构提供的匿名采购案例和设备生命週期记录进行定量最后覆核。在整个过程中，我们应用了资料检验技术，包括来源三角验证、一致性检查和专家小组审查，以确保分析的严谨性并减少潜在的偏差。

本调查方法强调透明度和可重复性，所有假设均有记录，访谈资料均已存檔，并可根据新的临床证据和技术发展对分析方法进行更新。相关人员希望了解调查方法或进行客製化分析，欢迎直接联繫调查团队进行专门检验。

影响SPECT实施成功及其长期临床价值的技术、操作和策略因素概述

总而言之，SPECT仍然是一种重要且适应性强的显像模式，其近期发展轨迹将取决于检测器创新、软体驱动的影像品质提升以及由营运优先顺序和供应链动态动态驱动的采购模式转变。积极将技术选择与临床应用案例相结合，并优先考虑模组化升级、完善的服务协议和循证实践的相关人员，将更有利于把技术进步转化为诊断信心和患者吞吐量方面的可衡量提升。

关税相关的供应链中断和区域差异凸显了弹性筹资策略和基于情境的采购规划的必要性。同时，竞争格局有利于那些将硬体差异化、可靠的售后支援以及在证据生成方面开展合作的供应商。随着临床界对更高解析度、更快采集速度和定量输出的需求不断增长，先进检测器和智慧重建技术的结合将引领下一波SPECT应用浪潮。

对 SPECT 技术的投资应得到培训、标准化方案和供应商关係的有力支持，以确保长期的临床和财务永续性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧演算法整合到SPECT扫描中，以提高影像重建精度和诊断可靠性
  • 开发用于远端心臟和神经系统评估的可携式SPECT成像设备
  • 利用靶向神经发炎生物标记的新型放射性药物追踪剂来提高阿兹海默症早期检测率
  • 扩展混合SPECT/CT影像系统，以实现肿瘤诊断中更精确的解剖定位
  • 在基于定量SPECT的放射性药物治疗计划中，对个人化剂量测定通讯协定的需求日益增长。
  • 一种新型99mTc标记心肌灌注剂已获得监管部门核准，用于改善慢性冠状动脉疾病的治疗
  • 实施云端基础的SPECT资料管理平台，以加强多中心协作研究和远端医疗分析
  • 固体检测器技术的进步将提高下一代SPECT相机的灵敏度和空间解析度。
  • 标准化定量软体在利用SPECT进行帕金森氏症进展的可重复纵向监测的应用日益广泛
  • 利用SPECT分子影像技术评估PSMA标靶放射性示踪剂在前列腺癌分期中的临床研究数量迅速增加。

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 单光子发射电脑断层扫描市场（依检测器）

  • CZT
  • NAI闪烁
  • 固态
    • 锗半导体
    • 硅光电倍增器

9. 单光子发射电脑断层扫描市场（依最终用户划分）

  • 诊断中心
  • 医院
    • 私立医院
    • 公立医院
  • 研究所

10. 单光子发射电脑断层扫描市场（依产品划分）

  • 双头
  • 单头
  • 三头

第十一章 单光子发射电脑断层扫描市场（依应用领域划分）

  • 心臟病学
  • 神经病学
  • 肿瘤学

12. 单光子发射电脑断层扫描市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 单光子发射电脑断层扫描市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国单光子发射电脑断层扫描市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Spectrum Dynamics Medical Ltd.
    • Digirad Corporation
    • Neusoft Medical Systems Co., Ltd.
    • Mediso Medical Imaging Systems Ltd.
    • Shimadzu Corporation
    • Hitachi, Ltd.
Product Code: MRR-02026C4CB810

The Single Photon Emission Computed Tomography Market is projected to grow by USD 3.02 billion at a CAGR of 4.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.19 billion
Estimated Year [2025] USD 2.28 billion
Forecast Year [2032] USD 3.02 billion
CAGR (%) 4.08%

A concise introduction to the current SPECT landscape highlighting clinical reliance, technological shifts, and procurement considerations for diagnostic leaders

Single Photon Emission Computed Tomography (SPECT) remains a cornerstone modality in nuclear medicine, combining functional imaging with widespread clinical utility across cardiology, neurology, and oncology. Technological evolution over the last decade has shifted the modality from analog detector paradigms toward digital and solid-state architectures, enabling improved count sensitivity, spatial resolution, and workflow integration. These advances are occurring in parallel with changes in radiopharmaceutical logistics, imaging protocols, and clinical pathways that collectively influence adoption and upgrade cycles in diagnostic centers and hospital systems.

Clinicians continue to rely on SPECT for myocardial perfusion imaging, brain perfusion assessments, and targeted oncologic studies where metabolic and receptor-based imaging complements anatomical techniques. As healthcare systems emphasize value-based outcomes and diagnostic efficiency, SPECT's adaptability-through diverse detector technologies and modular product configurations-supports a range of clinical use cases from high-volume cardiology labs to specialized research institutes. Consequently, procurement leaders and imaging directors must weigh clinical requirements, facility throughput, and lifecycle costs when planning equipment refreshes or new deployments.

Transitioning from established practice to innovation-led deployment requires careful alignment of technical performance with clinical protocols. Therefore, stakeholders should appraise detector options, head configurations, and service models in light of evolving clinical guidelines and operational priorities to ensure systems deliver measurable improvements in diagnostic confidence and patient throughput.

How detector breakthroughs, AI-driven reconstruction, and evolving clinical workflows are redefining diagnostic expectations and procurement strategies in SPECT imaging

The SPECT landscape is undergoing transformative shifts driven by convergence of detector innovation, software intelligence, and altered clinical workflows. New detector technologies are moving systems away from large-volume sodium iodide crystals toward compact cadmium zinc telluride and advanced solid-state sensors that offer intrinsic energy resolution and reduced dead time. Concurrently, image reconstruction algorithms and AI-enabled post-processing are enhancing lesion detectability and quantification, which is changing expectations for diagnostic accuracy and reporting timelines.

Operationally, hybrid imaging strategies and multimodality integration are reshaping how SPECT is positioned within diagnostic pathways; clinicians increasingly combine functional SPECT data with CT-derived attenuation correction and anatomical correlation, improving diagnostic confidence. At the same time, shifts in healthcare delivery-such as outpatient imaging consolidation and the proliferation of dedicated cardiac imaging centers-are altering procurement priorities toward systems that balance throughput with cost-efficiency. Supply chain dynamics and regulatory evolution are also prompting manufacturers and adopters to pursue diversified sourcing strategies and modular upgrade paths.

Taken together, these shifts create both opportunity and complexity: opportunities to enhance clinical utility and patient-centric workflows, and complexity in aligning technology selection with long-term serviceability, radiopharmaceutical availability, and evolving reimbursement models. Strategic planning must therefore reconcile rapid technological progress with sustainable operational models.

Assessing how cumulative tariff actions are reshaping supply chains, procurement timelines, and sourcing strategies for SPECT system manufacturers and healthcare providers

Recent tariff measures in the United States have introduced heightened sensitivity across global medical device supply chains, with cumulative implications for manufacturers, distributors, and end users of SPECT systems. Components such as semiconductor detectors, precision mechanical parts, and specialized electronics are vulnerable to tariff-induced cost pressures, which can increase landed costs and complicate capital procurement cycles for hospitals and diagnostic centers. In response, manufacturers are reassessing sourcing footprints and supply contracts to mitigate exposure while preserving product availability.

Consequently, many suppliers have accelerated localization of key components, established alternate supplier relationships, and adjusted logistics strategies to reduce tariff risk. These adaptations often entail nearshoring assembly operations, renegotiating supplier terms, and redesigning product architectures to use more readily sourced subsystems. Procurement teams are reacting by extending lead times in capital planning and prioritizing supplier stability and long-term service agreements over short-term price advantages.

From an operational standpoint, imaging centers may encounter longer procurement timelines and elevated acquisition costs that influence upgrade pacing and prioritization of high-throughput installations. Clinicians and administrators should therefore factor tariff-related supply chain uncertainty into capital planning, replacing assumptions of stable component availability with scenario-based procurement roadmaps that emphasize flexibility, lifecycle service support, and contractual protections against volatile input costs.

Deep segmentation-driven insights linking detector technologies, end-user priorities, product architectures, and clinical applications to procurement and clinical strategy

Detector technology segmentation reveals a clear divergence in clinical priorities: cadmium zinc telluride detectors and advanced solid-state options, including germanium semiconductors and silicon photomultipliers, are valued for superior energy resolution and count sensitivity, particularly in applications requiring small-lesion detection. By contrast, sodium iodide scintillation remains prevalent where cost efficiency and established workflows dominate, sustaining its presence in many diagnostic centers with large imaging volumes. These detector distinctions influence not only image quality but also service requirements, training needs, and capital allocation decisions.

End-user segmentation highlights differentiated procurement drivers across diagnostic centers, hospitals, and research institutes. Diagnostic centers prioritize throughput and cost-per-scan efficiency and therefore often favor systems with simplified workflows and rapid reconstruction. Hospitals, both private and public, balance clinical versatility with budgetary constraints; private hospitals may prioritize premium detectors and integrated service packages to support competitive positioning, whereas public hospitals frequently emphasize robust uptime, standardized protocols, and long-term maintenance contracts. Research institutes favor configurability and advanced detection technologies that enable protocol development and exploratory applications.

Product configuration also informs purchasing decisions: single-head systems appeal in space-constrained or low-volume settings, dual-head instruments offer balanced throughput and flexibility for general cardiology and oncology applications, and triple-head systems are selected where high sensitivity and faster acquisition are essential. Application segmentation into cardiology, neurology, and oncology continues to shape system requirements, with cardiology driving demand for rapid gated protocols, neurology emphasizing perfusion quantification, and oncology requiring compatibility with targeted tracers and quantitative workflows. Collectively, these segmentation layers determine the technical specifications, service models, and acquisition priorities that stakeholders must reconcile when selecting SPECT solutions.

Regional dynamics and adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, deployment, and serviceability of SPECT systems

Regional dynamics exert strong influence over adoption patterns and strategic priorities for SPECT systems, with the Americas exhibiting concentrated demand in advanced cardiac imaging and a robust vendor ecosystem that supports rapid clinical translation of detector innovations. In this region, private imaging centers and hospital networks often prioritize throughput and integrated service agreements, creating fertile ground for modular system upgrades and premium detector deployments. Regulatory environments and reimbursement frameworks further shape how new technologies are evaluated and adopted in clinical practice.

In Europe, the Middle East and Africa, the landscape is more heterogeneous; high-income European markets show steady uptake of advanced digital detectors and hybrid workflows, while markets across the Middle East and Africa are characterized by selective investments concentrated in tertiary hospitals and specialty centers. These geographies often emphasize reliability and long-term serviceability, given the logistical complexities of cross-border parts supply. Meanwhile, Asia-Pacific demonstrates rapid modernization in imaging infrastructure, driven by expanding middle-class healthcare demand, investment in specialized cardiac and oncologic centers, and local manufacturing initiatives that can lower acquisition barriers for advanced detector systems.

Across all regions, localized factors such as radiopharmaceutical availability, training ecosystems, and healthcare policy priorities shape how facilities prioritize upgrades and deploy SPECT systems. As a result, regional strategy must integrate clinical needs, supply chain resilience, and regulatory compliance to optimize deployment and ensure sustainable operations.

How competitive positioning, service excellence, and partnerships between hardware innovators and software developers are shaping the SPECT vendor landscape

Competitive dynamics in the SPECT ecosystem are governed by a mix of multinational imaging manufacturers and specialized firms that emphasize detector innovation or niche clinical solutions. Large, established medical imaging companies continue to leverage global service networks and integrated product portfolios to secure institutional contracts and deliver predictable lifecycle support, while smaller specialists differentiate through cutting-edge detector technologies, compact form factors, or software-driven image enhancement. Partnerships between device manufacturers and software developers are increasingly important, enabling iterative updates to reconstruction algorithms and AI-supported diagnostic aids.

Service and aftermarket support represent a decisive competitive axis: vendors that offer comprehensive training programs, predictive maintenance, and rapid parts availability tend to secure longer-term contracts with hospitals and diagnostic chains. Additionally, collaborative initiatives with radiopharmaceutical suppliers and clinical research organizations strengthen a supplier's value proposition by facilitating multi-center studies and protocol standardization. Capital equipment procurement committees and imaging directors therefore evaluate vendors not only on device performance but on the total cost of ownership, upgrade pathways, and demonstrated clinical outcomes.

Innovation pipelines focus on detector miniaturization, enhanced energy discrimination, and software platforms that improve quantitative reporting. This combination of hardware and software advancement provides new entrants with avenues to challenge incumbent offerings, while incumbents invest in acquisition, partnership, and internal R&D programs to maintain relevance. Ultimately, competitive success depends on aligning technical differentiation with dependable service models and evidence of clinical impact.

Actionable strategic imperatives for healthcare executives and vendors to align procurement, clinical utility, and supply chain resilience when adopting SPECT technologies

Industry leaders planning investments in SPECT technology should prioritize modularity, supply chain resilience, and clinical alignment to future-proof capital decisions. When specifying new systems, decision-makers should require flexible upgrade paths that allow detector or software improvements without full system replacement, thereby protecting capital while enabling performance enhancements as clinical needs evolve. Procurement strategies must also incorporate supplier diversification and contractual protections to mitigate tariff-driven and geopolitical supply disruptions.

Clinically, organizations should align acquisition criteria with high-impact applications: prioritize systems that demonstrably improve diagnostic confidence in cardiology, neurology, or oncology workflows and that integrate seamlessly with PACS and reporting infrastructures. Investing in staff training and protocol harmonization enhances the clinical value of advanced detectors and reconstruction software, ensuring that improved imaging performance translates into better patient management. From an operational perspective, emphasize total lifecycle support agreements and spare-part logistics to maximize uptime and predictable operating costs.

Finally, collaboration with industry partners on pilot studies and phased rollouts can de-risk adoption while generating local evidence of clinical and operational benefits. By combining flexible technical specifications with robust service frameworks and evidence-generating partnerships, leaders can secure imaging assets that deliver sustained clinical value and operational resilience.

A rigorous multi-method research approach combining clinician interviews, technical validation, and secondary literature synthesis to ensure reliable and transparent insights into SPECT technologies

This research was developed using a multi-method approach that triangulates primary stakeholder inputs with curated secondary sources and technical validation. Primary research included structured interviews with clinical end users, imaging physicists, procurement officers, and device engineers to capture frontline perspectives on performance requirements, operational challenges, and service expectations. These qualitative insights were supplemented by consultations with regulatory specialists to interpret approval pathways and compliance implications that affect device deployment timelines.

Secondary research encompassed peer-reviewed literature, clinical guidelines, manufacturer technical specifications, and publicly available regulatory filings to establish a robust evidence base on detector performance characteristics, imaging protocols, and application-specific requirements. Quantitative cross-checks were performed where feasible through anonymized procurement case studies and device lifecycle records provided by participating institutions. Throughout the process, data validation techniques such as source triangulation, consistency checks, and expert panel review were applied to ensure analytic rigor and mitigate potential bias.

The methodology emphasizes transparency and reproducibility: assumptions are documented, interview instruments are archived, and the analytical framework is designed to accommodate updates as new clinical evidence and technological developments emerge. Stakeholders seeking methodological clarification or bespoke analysis were invited to engage directly with the research team for tailored validation exercises.

Concluding synthesis of technological, operational, and strategic factors that will determine successful SPECT adoption and long-term clinical value

In conclusion, SPECT remains a vital and adaptable imaging modality whose near-term trajectory is defined by detector innovation, software-enabled image quality gains, and shifting procurement paradigms driven by operational priorities and supply chain dynamics. Stakeholders that proactively align technical selections with clinical use cases-prioritizing modular upgrades, robust service agreements, and evidence generation-will be best positioned to translate technological advances into measurable improvements in diagnostic confidence and patient throughput.

Tariff-related supply chain disruptions and regional heterogeneity underscore the need for flexible sourcing strategies and scenario-based procurement planning. Meanwhile, the competitive landscape rewards vendors that couple hardware differentiation with dependable aftermarket support and collaborative evidence-generation efforts. As the clinical community continues to demand higher resolution, faster acquisitions, and quantitative outputs, the combination of advanced detectors and intelligent reconstruction will shape the next wave of SPECT deployments.

Moving forward, organizations should balance innovation adoption with operational resilience, ensuring that investments in SPECT technology are underpinned by training, standardized protocols, and supplier relationships that support long-term clinical and financial sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms to enhance image reconstruction accuracy and diagnostic confidence in SPECT scans
  • 5.2. Development of portable SPECT imaging devices enabling point-of-care cardiac and neurological assessments in remote settings
  • 5.3. Adoption of novel radiopharmaceutical tracers targeting neuroinflammation biomarkers to improve early detection of Alzheimer's disease
  • 5.4. Expansion of hybrid SPECT/CT imaging systems for superior anatomical localization in oncology diagnostics
  • 5.5. Growing demand for personalized dosimetry protocols in radiopharmaceutical therapy planning based on quantitative SPECT metrics
  • 5.6. Regulatory approvals of new 99mTc-labeled myocardial perfusion agents for improved chronic coronary disease management
  • 5.7. Implementation of cloud-based SPECT data management platforms for enhanced multicenter collaboration and telemedicine analyses
  • 5.8. Advancements in solid-state detector technologies to boost sensitivity and spatial resolution of next-generation SPECT cameras
  • 5.9. Increasing adoption of standardized quantification software for reproducible longitudinal monitoring of Parkinson's disease progression via SPECT
  • 5.10. Surge in clinical studies evaluating PSMA-targeted radiotracers for prostate cancer staging using SPECT molecular imaging modalities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single Photon Emission Computed Tomography Market, by Detector

  • 8.1. Czt
  • 8.2. Nai Scintillation
  • 8.3. Solid State
    • 8.3.1. Germanium Semiconductor
    • 8.3.2. Silicon Photomultiplier

9. Single Photon Emission Computed Tomography Market, by End User

  • 9.1. Diagnostic Centers
  • 9.2. Hospitals
    • 9.2.1. Private Hospitals
    • 9.2.2. Public Hospitals
  • 9.3. Research Institutes

10. Single Photon Emission Computed Tomography Market, by Product

  • 10.1. Dual Head
  • 10.2. Single Head
  • 10.3. Triple Head

11. Single Photon Emission Computed Tomography Market, by Application

  • 11.1. Cardiology
  • 11.2. Neurology
  • 11.3. Oncology

12. Single Photon Emission Computed Tomography Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Single Photon Emission Computed Tomography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Single Photon Emission Computed Tomography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. GE HealthCare Technologies Inc.
    • 15.3.2. Siemens Healthineers AG
    • 15.3.3. Koninklijke Philips N.V.
    • 15.3.4. Canon Medical Systems Corporation
    • 15.3.5. Spectrum Dynamics Medical Ltd.
    • 15.3.6. Digirad Corporation
    • 15.3.7. Neusoft Medical Systems Co., Ltd.
    • 15.3.8. Mediso Medical Imaging Systems Ltd.
    • 15.3.9. Shimadzu Corporation
    • 15.3.10. Hitachi, Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CZT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NAI SCINTILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GERMANIUM SEMICONDUCTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SILICON PHOTOMULTIPLIER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DUAL HEAD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SINGLE HEAD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TRIPLE HEAD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 246. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 247. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 248. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 249. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 252. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 253. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 255. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2018-2024 (USD MILLION)
  • TABLE 274. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR, 2025-2032 (USD MILLION)
  • TABLE 275. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOLID STATE, 2018-2024 (USD MILLION)
  • TABLE 276. BRICS SINGLE